SBIR/STTR Research Award
GLUCOSE MICROMONITOR WITH RADIO INTERFACE
Award amount
$100,000Program and phase
SBIR · Phase IAward year
2002Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- MINFORMED, LLC
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- Not reported
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
Description (provided by applicant): The proposed research is aimed at
developing a fully-integrated non-invasive ambulatory blood glucose monitor
with interference abatement using optical absorption through the skin aimed at
diabetic applications (health relatedness). The goal is to overcome current
problems such as "baseline drift" and self-calibration by measuring optical
absorption of every blood analyte comparable to glucose (about 28). Innovative
methods will be used to decompose the measured spectrum enabling interferences
with glucose measurement to be corrected, especially effects of the skin. An
innovative self-calibration method is included. The specific aims are
feasibility of: 1) data collection methods aimed at measuring blood glucose
through the skin, 2) the least squares data analysis methods, 3) micromonitor
integration (miniaturization of data collection hardware), 4) pocket monitor
(data analysis hardware), software, and other peripheral needs. User interface
requirements will be evaluated including PDA requirements, ability to download
to a PC for further calculations, archival, trending, and needs of medical
personnel. The primary thrust will be Aims 1) and 2) establishing the
feasibility of the techniques for sensing and analysis. Aims 3) and 4) are
paper feasibility assessments needed for Phase II.
PROPOSED COMMERCIAL APPLICATION: It is well known that the commercial application of such research is enormous. Two percent of the world's population is thought to be diabetic. Perhaps 114 million indivie=duals worldwide, 16 million in the United States require regular monitoring. The market size is measured in the billions of dollars. In addition, other emerging markets, such as the artificial pancreas, will further multiply demand for our glucose monitoring technology.
Technology keywords
Not reported